Freedom of Information Request: 0386 2019/20
Recently NICE approved the use of risankizumab (Skyrizi) for treating moderate to severe plaque psoriasis in adults.
Do you have any patients on this treatment? If yes, how many?
Yes, 3 patients
October 18, 2019
Last updated: October 18, 2019
Freedom of Information Request: 0386 2019/20
Recently NICE approved the use of risankizumab (Skyrizi) for treating moderate to severe plaque psoriasis in adults.
Do you have any patients on this treatment? If yes, how many?
Yes, 3 patients
Thinking of going to Accident and Emergency but not sure if you need to? Try our handy symptom checker.
Try ask A&EWe're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.
